SKAN Group AG
SIX:SKAN

Watchlist Manager
SKAN Group AG Logo
SKAN Group AG
SIX:SKAN
Watchlist
Price: 74 CHF -0.8%
Market Cap: 1.7B CHF
Have any thoughts about
SKAN Group AG?
Write Note

Net Margin
SKAN Group AG

9.4%
Current
6%
Average
0%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
9.4%
=
Net Income
32.2m
/
Revenue
344m

Net Margin Across Competitors

Country CH
Market Cap 1.7B CHF
Net Margin
9%
Country US
Market Cap 1.3T USD
Net Margin
9%
Country US
Market Cap 196.2B USD
Net Margin
14%
Country US
Market Cap 170.9B USD
Net Margin
18%
Country KR
Market Cap 67.6T KRW
Net Margin
24%
Country CH
Market Cap 38.5B CHF
Net Margin
9%
Country US
Market Cap 38.6B USD
Net Margin
22%
Country US
Market Cap 36.5B USD
Net Margin
9%
Country US
Market Cap 26.7B USD
Net Margin
21%
Country US
Market Cap 23.2B USD
Net Margin
17%
Country US
Market Cap 23B USD
Net Margin
21%
No Stocks Found

SKAN Group AG
Glance View

Market Cap
1.7B CHF
Industry
Life Sciences Tools & Services

SKAN Group AG engages in the development, design, and manufacture of process isolators for the aseptic filling of biopharmaceutical products. The company is headquartered in Allschwil, Basel-Landschaft. The company went IPO on 2007-04-05. The company concentrates on companies from the industry, micro and medical technology, processing and material technology, information technology and related services. Target enterprises are those being in special situations, such as management buy-out and buy-in, changes in shareholders’ structure, succession financing, as well as coming through growth or expansion phase. The firm acts as an entrepreneurial partner in the long term. Operational activities are delegated to the independent advisor BV Partners AG. BV Holding AG and BV Partners AG form the BVgroup. As of December 31, 2011, its investment portfolio included nine companies: Covalys BioSciences AG, E2E Technologies Ltd., Lonstroff Holding AG, Piexon AG, POLYDATA AG, SKAN Holding AG, Sphinx Werkzeuge AG, Ypsomed Holding AG and Ziemer Group AG.

SKAN Intrinsic Value
93.59 CHF
Undervaluation 21%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
9.4%
=
Net Income
32.2m
/
Revenue
344m
What is the Net Margin of SKAN Group AG?

Based on SKAN Group AG's most recent financial statements, the company has Net Margin of 9.4%.